[Secondary prevention of ischemic stroke: laboratory and imaging biomarkers]

Mira Katan1, Susanne Wegener1

  • 1Klinik für Neurologie, Universitätsspital Zürich und Universität Zürich.

Insights

Identifying stroke causes is key to preventing recurrence. New laboratory and imaging biomarkers aid in better stroke etiology stratification for improved secondary prevention strategies.

Area of Science:

  • Neurology
  • Biomarkers
  • Stroke Medicine

Background:

  • Stroke recurrence is a significant concern, necessitating accurate etiological diagnosis.
  • Current etiological classification includes large artery atherosclerosis, cardiac embolism, and small vessel disease.
  • Identifying the precise cause of ischemic stroke is crucial for effective secondary prevention.

Purpose of the Study:

  • To review current knowledge on laboratory and imaging biomarkers for ischemic stroke secondary prevention.
  • To highlight the potential of these biomarkers in clinical stroke patient care.
  • To improve the stratification of stroke etiology using novel biomarkers.

Main Methods:

  • Literature review of recent studies on biomarkers in stroke secondary prevention.
  • Analysis of laboratory and imaging techniques for etiological diagnosis.
  • Synthesis of current evidence on biomarker utility in stroke patient management.

Main Results:

  • Biomarkers show promise in refining stroke etiological classification.
  • Laboratory and imaging biomarkers can aid in stratifying patients based on stroke cause.
  • These advancements have the potential to personalize secondary stroke prevention.

Conclusions:

  • Biomarkers are increasingly important in understanding and preventing stroke recurrence.
  • Further research and clinical integration of biomarkers are needed for optimal stroke care.
  • Biomarker-guided secondary prevention strategies are anticipated to improve patient outcomes.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
54
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
173
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
113
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
448